Bliss GVS Pharma Limited (NSE:BLISSGVS)
India · Delayed Price · Currency is INR 652.35
-2.40 (-0.37%)
Nov 11, 2026, 1:20 PM IST
Bliss GVS Pharma Market Cap
Bliss GVS Pharma has a market cap or net worth of 68.98 billion as of November 10, 2026. Its market cap has increased by 341.29% in one year.
Market Cap
68.98B
Enterprise Value
67.69B
Revenue
10.74B
Global Rank
n/a
Country Rank
n/a
PE Ratio
43.83
ChartMarket Cap Chart
Since January 11, 2002, Bliss GVS Pharma's market cap has increased from 10.05M to 68.98B, an increase of 686,115.84%. That is a compound annual growth rate of 42.69%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 11, 2026 | 68.98B | 298.80% |
| Dec 31, 2025 | 17.30B | -0.33% |
| Dec 31, 2024 | 17.35B | 33.41% |
| Dec 29, 2023 | 13.01B | 72.15% |
| Dec 30, 2022 | 7.56B | -29.58% |
| Dec 31, 2021 | 10.73B | -48.57% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| NATCO Pharma | 157.79B |
| Sudeep Pharma | 136.70B |
| Akums Drugs and Pharmaceuticals | 117.25B |
| Strides Pharma Science | 92.38B |
| Aarti Pharmalabs | 83.55B |
| Sun Pharma Advanced Research Company | 68.41B |
| Innova Captab | 61.17B |
| Orchid Pharma | 52.94B |